SI1849470T1 - Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze - Google Patents
Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilazeInfo
- Publication number
- SI1849470T1 SI1849470T1 SI200632192T SI200632192T SI1849470T1 SI 1849470 T1 SI1849470 T1 SI 1849470T1 SI 200632192 T SI200632192 T SI 200632192T SI 200632192 T SI200632192 T SI 200632192T SI 1849470 T1 SI1849470 T1 SI 1849470T1
- Authority
- SI
- Slovenia
- Prior art keywords
- alpha
- trifluorothymidine
- anticancer drug
- drug containing
- phosphorylase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/042,059 US7799783B2 (en) | 2005-01-26 | 2005-01-26 | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor |
JP2005165156 | 2005-06-06 | ||
PCT/JP2006/301097 WO2006080327A1 (ja) | 2005-01-26 | 2006-01-25 | α,α,α-トリフルオロチミジンとチミジンホスホリラーゼ阻害剤とを配合した抗癌剤 |
EP06712292.9A EP1849470B2 (en) | 2005-01-26 | 2006-01-25 | Anticancer drug containing alpha, alpha, alpha-trifluorothymidine and thymidine phosphorylase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1849470T1 true SI1849470T1 (sl) | 2017-10-30 |
Family
ID=36740357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200632192T SI1849470T1 (sl) | 2005-01-26 | 2006-01-25 | Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1849470B2 (sl) |
JP (1) | JP5576591B2 (sl) |
KR (1) | KR101468216B1 (sl) |
AU (1) | AU2006209547C1 (sl) |
CA (1) | CA2594713A1 (sl) |
CY (2) | CY1119393T1 (sl) |
DK (1) | DK1849470T4 (sl) |
ES (1) | ES2630002T3 (sl) |
FI (1) | FI1849470T4 (sl) |
HU (2) | HUE033306T2 (sl) |
LT (2) | LT1849470T (sl) |
LU (1) | LUC00036I2 (sl) |
NL (1) | NL300889I2 (sl) |
PL (1) | PL1849470T3 (sl) |
PT (1) | PT1849470T (sl) |
RU (1) | RU2394581C2 (sl) |
SI (1) | SI1849470T1 (sl) |
TW (1) | TWI362265B (sl) |
WO (1) | WO2006080327A1 (sl) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
SI1849470T1 (sl) | 2005-01-26 | 2017-10-30 | Taiho Pharmaceutical Co., Ltd. | Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
JP5852309B2 (ja) * | 2007-04-25 | 2016-02-03 | サイクラセル リミテッド | 増殖性疾患を治療するためのサパシタビンの使用 |
BRPI0906467C1 (pt) | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada |
WO2009135680A1 (en) | 2008-05-09 | 2009-11-12 | Grünenthal GmbH | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
CA2723944A1 (en) * | 2008-05-15 | 2009-11-19 | Jan Balzarini | Anti-cancer combination therapy |
EP2456427B1 (en) | 2009-07-22 | 2015-03-04 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
CN102639118B (zh) | 2009-07-22 | 2015-07-29 | 格吕伦塔尔有限公司 | 氧化稳定的抗干扰剂型 |
WO2012028318A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising an anionic polymer |
EP2611426B1 (en) | 2010-09-02 | 2014-06-25 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
DK2736495T3 (da) | 2011-07-29 | 2017-11-13 | Gruenenthal Gmbh | Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel |
HUE034710T2 (hu) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta |
RS56911B1 (sr) | 2011-08-16 | 2018-05-31 | Taiho Pharmaceutical Co Ltd | Antitumorni agens i postupak predviđanja terapijskog efekta za pacijente sa kolorektalnim kancerom sa kras-mutacijom |
TWI503122B (zh) | 2012-02-15 | 2015-10-11 | Taiho Pharmaceutical Co Ltd | Oral administration of pharmaceutical compositions |
TWI526210B (zh) * | 2012-02-15 | 2016-03-21 | Taiho Pharmaceutical Co Ltd | Oral pharmaceutical composition |
CA2864949A1 (en) | 2012-02-28 | 2013-09-06 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
EP2829611A4 (en) | 2012-03-14 | 2015-12-02 | Nisshin Pharma Inc | SULFURAMINOUS-SUSTAINABLE COMPOSITION |
WO2013156453A1 (en) | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
CA2872526A1 (en) | 2012-05-16 | 2013-11-21 | Novartis Ag | Dosage regimen for a pi-3 kinase inhibitor |
AU2014245147B2 (en) * | 2013-03-27 | 2017-08-31 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent including low-dose irinotecan hydrochloride hydrate |
SI2979701T1 (sl) * | 2013-03-27 | 2021-02-26 | Taiho Pharmaceutical Co., Ltd. | Ptotitumorsko sredstvo z irinotekan hidroklorid hidratom |
TWI595879B (zh) * | 2013-05-17 | 2017-08-21 | Taiho Pharmaceutical Co Ltd | Prediction of therapeutic effect in patients with colorectal cancer with TK1 protein hyperactivity |
EP3003279A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
AU2014273226B2 (en) | 2013-05-29 | 2019-06-27 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
KR20160031526A (ko) | 2013-07-12 | 2016-03-22 | 그뤼넨탈 게엠베하 | 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형 |
EP4201424A1 (en) | 2013-09-06 | 2023-06-28 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent and antitumor effect enhancer |
EP3073994A1 (en) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
AU2015261060A1 (en) | 2014-05-12 | 2016-11-03 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising Tapentadol |
CN106456550A (zh) | 2014-05-26 | 2017-02-22 | 格吕伦塔尔有限公司 | 避免乙醇剂量倾泻的多颗粒 |
CA2983642A1 (en) | 2015-04-24 | 2016-10-27 | Grunenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
KR102281961B1 (ko) | 2016-01-08 | 2021-07-26 | 다이호야쿠힌고교 가부시키가이샤 | 면역 조절제를 함유하는 항종양제 및 항종양 효과 증강제 |
WO2017135412A1 (ja) | 2016-02-05 | 2017-08-10 | 大鵬薬品工業株式会社 | 重度腎機能障害を有する癌患者に対する治療方法 |
EP3730935A4 (en) | 2017-12-22 | 2022-02-23 | Taiho Pharmaceutical Co., Ltd. | METHOD OF DETECTING ANALOGUES OF TRIFLURIDIN AND/OR TIPIRACIL |
US10866219B2 (en) | 2017-12-22 | 2020-12-15 | Taiho Pharmaceutical Co., Ltd. | Method for detecting trifluridine- and/or tipiracil-related substance |
US10816517B2 (en) | 2018-01-05 | 2020-10-27 | Taiho Pharmaceutical Co., Ltd. | Method for detecting trifluridine-related substance by high-performance liquid chromatography |
WO2019135405A1 (ja) | 2018-01-05 | 2019-07-11 | 大鵬薬品工業株式会社 | トリフルリジン由来の類縁物質の検出方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2191340C (en) * | 1995-03-29 | 2001-04-17 | Shingo Yano | Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
PT884051E (pt) * | 1996-09-24 | 2005-03-31 | Taiho Pharmaceutical Co Ltd | Inibidores de metasteses cancerosas contendo derivados de uracilo |
SI1849470T1 (sl) | 2005-01-26 | 2017-10-30 | Taiho Pharmaceutical Co., Ltd. | Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze |
-
2006
- 2006-01-25 SI SI200632192T patent/SI1849470T1/sl unknown
- 2006-01-25 CA CA002594713A patent/CA2594713A1/en not_active Withdrawn
- 2006-01-25 PL PL06712292T patent/PL1849470T3/pl unknown
- 2006-01-25 WO PCT/JP2006/301097 patent/WO2006080327A1/ja active Application Filing
- 2006-01-25 LT LTEP06712292.9T patent/LT1849470T/lt unknown
- 2006-01-25 EP EP06712292.9A patent/EP1849470B2/en active Active
- 2006-01-25 HU HUE06712292A patent/HUE033306T2/hu unknown
- 2006-01-25 JP JP2007500529A patent/JP5576591B2/ja active Active
- 2006-01-25 ES ES06712292.9T patent/ES2630002T3/es active Active
- 2006-01-25 RU RU2007132181/15A patent/RU2394581C2/ru active
- 2006-01-25 PT PT67122929T patent/PT1849470T/pt unknown
- 2006-01-25 DK DK06712292.9T patent/DK1849470T4/da active
- 2006-01-25 AU AU2006209547A patent/AU2006209547C1/en active Active
- 2006-01-26 TW TW095103114A patent/TWI362265B/zh active
-
2007
- 2007-07-19 KR KR1020077016492A patent/KR101468216B1/ko active IP Right Grant
-
2017
- 2017-07-28 LT LTPA2017024 patent/LTC1849470I2/lt unknown
- 2017-08-01 HU HUS1700032C patent/HUS1700032I1/hu unknown
- 2017-08-08 NL NL300889C patent/NL300889I2/nl unknown
- 2017-09-06 FI FIEP06712292.9T patent/FI1849470T4/fi active
- 2017-09-07 CY CY20171100947T patent/CY1119393T1/el unknown
- 2017-09-07 CY CY2017029C patent/CY2017029I2/el unknown
- 2017-09-29 LU LU00036C patent/LUC00036I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI1849470T4 (fi) | Syövän vastainen lääke sisältäen alfa,alfa,alfa-trifluoritymidiiniä ja tymidiinifosforylaasin estäjää | |
SI1913001T1 (sl) | (r)-n-metilnaltrekson, postopki za njega sintezo in njega farmacevtsko uporabo | |
SI1928882T1 (sl) | (s)-n-metilnaltrekson, postopek za njega sintezo in njega farmacevtska uporaba | |
EP1934820A4 (en) | DISTRIBUTED INTERMEDIATE STORAGE | |
IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
ZA200709856B (en) | Fluorene derivatives,compositions containing said derivatives and the use thereof | |
AP2008004533A0 (en) | Pharmaceutical combination | |
IL194751A0 (en) | Drugs and uses | |
PL2057153T3 (pl) | POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY | |
EP2034015A4 (en) | IMMUNOSTIMULATING OLIGONUCLEOTIDE AND ITS PHARMACEUTICAL APPLICATION | |
EP1863800A4 (en) | SYNTHESIS OF AVRAINVILLAMIDE, STEPHACIDINE B AND CORRESPONDING ANALOGUES | |
EP2005306A4 (en) | COMPARISON AND MATCHING PERMUTATION OPERATIONS | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
ZA200900673B (en) | 18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
IL198236A0 (en) | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof | |
EP2025667A4 (en) | 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS | |
SI1791872T1 (sl) | Biotinilirani heksadekasaharidi, farmacevtski sestavki in njihova uporaba | |
EP1915988A4 (en) | COMPRESSOR COMPRISING MULTIPLE SEGMENTS CONTAINING MEDICAMENTS | |
IL177759A0 (en) | Cospeptin, cosmedin and their uses | |
ZA200804666B (en) | Pharmaceutical combination | |
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
ZA201005396B (en) | 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative | |
TWI372053B (en) | Combination drug | |
IL191618A0 (en) | N-hydroxyamide derivatives, their preparation and use | |
AP2008004389A0 (en) | Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine |